Mycophenolate mofetil and Bactroban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Bactroban (mupirocin). Common drug interactions include maternal exposure during pregnancy among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Bactroban. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.



On Aug, 11, 2026

14 people who take Mycophenolate mofetil and Bactroban together, and have interactions are studied.

Mycophenolate mofetil and Bactroban drug interactions.

What are the common drug interactions of Mycophenolate Mofetil and Bactroban, by gender? *:

female:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Hospitalisation
  3. Burning sensation
  4. Hyperaesthesia
  5. Limb discomfort (discomfort in leg)
  6. Muscular weakness (muscle weakness)
  7. Neuropathy peripheral (surface nerve damage)
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Spinal compression fracture (fracture due to spinal compression on bone)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))
  3. Central nervous system infection (infection of brain or spinal cord)
  4. Cerebellar infarction (impaired blood circulation to cerebellum)
  5. Cerebellar ischaemia (lack of blood supply to cerebeller)
  6. Cerebral infarction (less blood supply to brain resulting tissue damage)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Chills (felling of cold)
  9. Cryptococcosis (potentially fatal fungal disease)
  10. Cytomegalovirus antigen positive

What are the common drug interactions of Mycophenolate Mofetil and Bactroban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Hospitalisation

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms)
  4. Erythema (redness of the skin)
  5. Fatigue (feeling of tiredness)
  6. Haemorrhage (bleeding)
  7. Iron deficiency anaemia
  8. Pain
  9. Photosensitivity reaction
  10. Pleuritic pain

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. H1n1 influenza (flu (influenza), which is caused by virus influenza a (h1n1))
  3. Central nervous system infection (infection of brain or spinal cord)
  4. Cerebellar infarction (impaired blood circulation to cerebellum)
  5. Cerebellar ischaemia (lack of blood supply to cerebeller)
  6. Cerebral infarction (less blood supply to brain resulting tissue damage)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Chills (felling of cold)
  9. Cryptococcosis (potentially fatal fungal disease)
  10. Cytomegalovirus antigen positive

What are the existing conditions these people have? *

  1. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 10 people, 71.43%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 8 people, 57.14%
  3. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 2 people, 14.29%
  4. Pain: 1 person, 7.14%
  5. Kidney Transplant Rejection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and Bactroban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mycophenolate mofetil and Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and mupirocin (the active ingredients of Mycophenolate mofetil and Bactroban, respectively), and Mycophenolate mofetil and Bactroban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: